Two new cholesterol drugs were shown to be safe and effective in new research presented at an annual meeting of the American Heart Association on Sunday.
U.S. officials granted full approval to a closely watched Alzheimer’s drug on Thursday, clearing the way for Medicare and other insurance plans to begin covering the treatment for people with the brain-robbing disease.